Xin Hua Cai Jing·2025-11-07 03:30Core Insights - The eighth China International Import Expo highlights innovation and collaboration in the global pharmaceutical and health sector, with Meituan Health making its debut and forming strategic partnerships with seven multinational pharmaceutical companies [1][2]. Group 1: Strategic Partnerships - Meituan Health has signed agreements with AstraZeneca, Bayer, Gilead Sciences, Pfizer, and others, focusing on various pharmaceutical categories, including both immediate need products and chronic disease medications [1]. - The collaboration includes channel expansion, joint development of customized new products, disease-specific education, and comprehensive health management solutions [1][2]. Group 2: Market Dynamics - Multinational pharmaceutical companies are shifting their focus from traditional e-commerce platforms to local health consumption channels to tap into new growth opportunities [1]. - Meituan Health has a user base of 300 million, with a strong growth trajectory, making it a preferred partner for multinational pharmaceutical companies looking to deepen their presence in the Chinese market [1]. Group 3: Specialized Drug Areas - Meituan has established deep cooperation agreements in specialized drug areas, including respiratory disease prevention with AstraZeneca and various digital treatment centers for conditions like migraines and psoriasis [2]. - The platform has a significant female user base, with partnerships in women's health being a key focus, particularly with Bayer, which has been a partner for five years [2]. Group 4: Digital Innovation and Services - The investment and engagement of multinational pharmaceutical companies on the Meituan platform are increasing, with foreign pharmaceutical companies making up 50% of the top 20 in the platform's digital brand engine rankings [2]. - Meituan Health has introduced innovative services such as professional cold chain delivery and a self-operated pharmacy air delivery network, achieving next-day delivery in over 300 cities [2].